Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Page 2

Well Doc recuperates with $1.6m
Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.
Harvard opens Lab1636 with $100m
Harvard has partnered Deerfield to launch commercialisation firm Lab1636 with $100m in funding in order to advance life science projects towards the clinic and establish spinouts.
Osage University Partners closes $273m fund
OUP has closed an oversubscribed third fund that it expects will invest in 40 to 50 spinouts, primarily originating from 19 core partner institutions.
UW Health brings forth Isthmus
The accelerator will support up to 12 health projects at a time, led by innovators including UW Health faculty and with resources provided by four partners including Warf.
Garwood to spark $3m series B
Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.
CIC turns up for Gyroscope
Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.
TriAltus takes on $1.6m
The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.
Big deal: Anaveon proves UZH fund model works
Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.
NemaMetrix clinches $5m
Oregon Venture Fund and Rogue Venture Partners have both backed University of Oregon's DNA testing services provider NemaMetrix to bring the spinout’s total to $8.5m.
Beam hits series B with $135m
GV participated as a new investor, as Harvard's genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

test reg

Login